Simple Three-Factor Score Predicts Who Can Finish R-CHOP Therapy in Older Lymphoma Patients
A retrospective study of 117 older patients with diffuse large B-cell lymphoma identified age, performance status and serum albumin as ...
A retrospective study of 117 older patients with diffuse large B-cell lymphoma identified age, performance status and serum albumin as ...
The clinical case for expanding access to CAR T-cell therapy in Brazil rests on a substantial body of evidence demonstrating ...
Danish researchers report that low-level skipping of CD19 exon 2, detectable in pre-treatment RNA-sequencing data, correlates with relapse after anti-CD19 ...
In a remarkable advance within the realm of immunotherapy, a new study published in the journal "Annals of Hematology" sheds ...
In a groundbreaking study poised to reshape therapeutic strategies against certain lymphomas, researchers have unveiled an unexpected mechanism by which ...
In a groundbreaking study published in Nature Genetics, researchers at The University of Texas MD Anderson Cancer Center have unveiled ...
Recent advancements in cancer therapy have spotlighted the transformative potential of chimeric antigen receptor (CAR) T-cell therapies, especially in the ...
In the relentless quest to uncover new therapeutic avenues for diffuse large B-cell lymphoma (DLBCL), a recent study published in ...
In a groundbreaking advancement in cancer research, scientists have uncovered a pivotal mechanism to combat diffuse large B-cell lymphoma (DLBCL), ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine